| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.00051 | 1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.00025 | 1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.00013 | 1 |